Renal Allograft Involvement by Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disease

American Journal of Surgical Pathology

Volumn 20, Issue 5, 1996, Pages 563-571

  Randhawa, P S ^a,b   Magnone, M ^a   Jordan, M ^a   Shapiro, R ^a   Demetris, A J ^a   Nalesnik, M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

Epstein Barr; Kidney; Lymphoproliferative; Post transplant

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; POSTOPERATIVE COMPLICATION;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRAFT REJECTION; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; NECROSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029988335     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199605000-00003     Document Type: Article

References (25)

1. Citterio F, Lauriola L, Nanni G, Vecchio FM, Magalini SC, Castagneto M. Polyclonal lymphoma confined to renal allograft: case report. Transplant Proc 1987;19:3732-4.
2. Cockfield SM, Preiksaitis J, Harvey E, et al. Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder? Transplant Proc 1991;23:1106-7.
3. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Posttransplant lymphoproliferative disorder in renal allograft recipients. Transplantation 1993;56:88-96.
4. Craig FE, Gulley ML, Banks PM. Post-transplantation lymphoproliferative disorders. Am J Clin Pathol 1993;99:265-76.
5. Deamant FD, Albujar PF, Chen YY, Weiss LM. Epstein-Barr virus distribution in neoplastic lymph nodes. Mod Pathol 1993;6:729-32.
6. Denning DW, Weiss LM, Martinez K, Flechner SM. Transmission of Epstein-Barr virus by a transplanted kidney, with activation by OKT3 antibody. Transplantation 1989;48: 141-4.
7. Dhir RK, Nalesnik MA, Demetris AJ, Randhawa PS. Latent membrane protein expression in post-transplant lymphoproliferative disease. Appl Immunohistochem 1995;3:123-6.
8. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985;39:461-72.
9. Hickey DP, Nalesnik MA, Vivas CA, et al. Renal retransplantation in patients who lost their allografts during management of previous post-transplant lymphoproliferative disease. Clin Transplantation 1990;4:187-90.
10. Hjelle B, Evans-Holm M, Yen TSB, Garovoy M, Guis M, Edman JC. A poorly differentiated lymphoma of donor origin in a renal allograft recipient. Transplantation 1989;47: 945-8.
11. Hubscher SG, Williams A, Davison SM, Young LS, Niedobitek G. Epstein-Barr virus in inflammatory diseases of the liver and liver allografts: an in-situ hybridization study. Hepatology 1994;20:899-907.
12. Houle AM, McLorie GA, Churchill BM, Khoury AE, Harvey E. Rapid development of an immunoblastic lymphoma and death in children following cadaveric renal transplantation. J Pediatr Surg 1992;27:626-8.
13. Jones C, Bleau B, Buskard N, et al. Simultaneous development of diffuse immunoblastic lymphoma in recipients of renal transplants from a single cadaver donor: transmission of Epstein-Barr virus and triggering by OKT3. Am J Kidney Dis 1994;23:130-4.
14. Lager DJ, Burgart LJ, Slagel DD. Epstein-Barr virus detection in sequential biopsies from patients with a posttransplant lymphoproliferative disorder. Mod Pathol 1993; 6:42-7.
15. Muso E, Fujiwara H, Youshida H, et al. Epstein-Barr virus genome-positive tubulointerstitial nephritis associated with Kawasaki disease-like coronary aneurysms. Clin Nephrol 1993;40:7-15.
16. Nadasdy T, Park CS, Peiper SC, Wenzl JE, Oates J, Silva FG. Epstein-Barr virus infection-associated renal disease: diagnostic use of molecular hybridization technology in patients with negative serology. J Am Soc Nephrol 1992;2: 1734-42.
17. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of post-transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosusppression. Am J Pathol 1988;133:173-92.
18. O'Brien JJ, Campoli-Richards DM. Acyclovir: an updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1989;37:233-309.
19. Purtilo DT, Strobach RS, Okano M, Davis JR. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 1992;67:5-23.
20. Renoult E, Kessler M. Lymphoproliferative disease confined to the renal allograft. French multicentric study. J Radiol 1994;75:53-6.
21. Seiden MV, Sklar J. Molecular genetic analysis of posttransplant lymphoproliferative disorders. Hematol Oncol Clin North Am 1993;7:447-65.
22. Shapiro RS, Chauvenet A, McGuire W, Pearson A, McGlave P. Treatment of B-cell lymphoproliferative disorders with interferon alpha and intravenous gamma globulin. N Engl J Med 1988;322:1334.
23. Sinniah R, Khan TN, Dodd S. An in situ hybridization study of herpes simplex and Epstein-Barr viruses in IgA nephropathy and non-immune glomerulonephritis. Clin Nephrol 1993;40:137-41.
24. Squiers EC, West JC, Leonard D, et al. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder presenting as perirenal transplant lymphocele. Transplantation 1993;56:1278.
25. Ulrich W, Chott A, Watschinger B, Reiter C, Kovarik J, Radaszkiewicz T. Primary peripheral T cell lymphoma in a kidney transplant under immunosuppression with cyclosporine A. Hum Pathol 1989;20;1027-1030.